Concepedia

Klaus D. Haisch

KD

8

Publications

351

Citations

8

H-Index

1982

Active since

Affiliations

Eli Lilly (United States)(Current)

Klaus D. Haisch is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1982–1987

8

Publications

8

LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.

J H Fleisch, Lynn E. Rinkema, Klaus D. Haisch et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 163 citations

Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives

Winston S. Marshall, Theodore Goodson, George J. Cullinan et al. · Journal of Medicinal Chemistry · 1987 · 67 citations

Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contraction.

J H Fleisch, Klaus D. Haisch, Stephen M. Spaethe · Journal of Pharmacology and Experimental Therapeutics · 1982 · 39 citations

Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives

Robert D. Dillard, F. Patrick Carr, Doris McCullough et al. · Journal of Medicinal Chemistry · 1987 · 24 citations · Full text

, , +14

Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.

J H Fleisch, Klaus D. Haisch, Stephen M. Spaethe et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 19 citations

Rows per page

1–5 of 8